Pharmacotherapy for alcohol use disorder (AUD) involves using medications to help individuals reduce or stop alcohol consumption. This chapter reviews management of acute alcohol withdrawal, Food and Drug Administration (FDA)-approved medications for AUD, non-FDA-approved medications, and future directions of AUD pharmacotherapy. It provides a detailed examination of the efficacy, mechanisms of action, and clinical applications of various pharmacotherapies, including naltrexone, acamprosate, disulfiram, gabapentin, topiramate, ondansetron, varenicline, baclofen, nalmefene, and prazosin.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pharmacotherapy for Alcohol Use Disorder

  • Ella Blicker

摘要

Pharmacotherapy for alcohol use disorder (AUD) involves using medications to help individuals reduce or stop alcohol consumption. This chapter reviews management of acute alcohol withdrawal, Food and Drug Administration (FDA)-approved medications for AUD, non-FDA-approved medications, and future directions of AUD pharmacotherapy. It provides a detailed examination of the efficacy, mechanisms of action, and clinical applications of various pharmacotherapies, including naltrexone, acamprosate, disulfiram, gabapentin, topiramate, ondansetron, varenicline, baclofen, nalmefene, and prazosin.